Main content area

Anti-Idiotype scFv–Enzyme Fusion Proteins: A Clonable Analyte-Mimicking Probe for Standardized Immunoassays Targeting Small Biomarkers

Oyama, Hiroyuki, Tanaka, Eri, Kawanaka, Tomoyo, Morita, Izumi, Niwa, Toshifumi, Kobayashi, Norihiro
Analytical chemistry 2013 v.85 no.23 pp. 11553-11559
alkaline phosphatase, antibodies, biomarkers, blood serum, colorimetry, cortisol, cross reaction, detection limit, enzyme activity, enzyme-linked immunosorbent assay, genes, haptens, mice, proteins, solvents
Most immunoassays use probes that convert concentrations of analytes into signal intensity. To prepare the probes, analytes are usually linked to a reporter protein (e.g., enzymes) with the aid of chemical reagents. However, these conventional methods yield a mixture of heterogeneous products and consequently reduce assay performance. “Clonable” homogeneous probes, i.e., recombinant molecules in which a target protein is genetically fused to a reporter with a defined coupling ratio, are now available for analyzing protein biomarker concentrations. Here, we have expanded this strategy to measure small biomarkers (haptens) by genetically fusing proteinaceous molecules that mimic target haptens with enzymes. 11-Deoxycortisol (11-DC) was chosen as the model hapten, and the β-type anti-idiotype antibodies (βId-Abs) that recognize the paratope of anti-hapten antibodies were used as the target hapten mimic. The VH and VL genes of a βId-Ab, targeting a mouse anti-11-DC antibody (CET-M8), were assembled to encode a single-chain Fv fragment (βId-scFv), which was then fused with a gene encoding a variant of alkaline phosphatase. The product, βId-scFv-ALP′ protein, had satisfactory enzyme activity and bound to CET-M8 in a competitive manner with 11-DC. A colorimetric enzyme-linked immunosorbent assay (ELISA) for 11-DC, based on the competitive reaction between the analyte and βId-scFv-ALP′ against immobilized CET-M8, was found to be sensitive (limit of detection = 22 pg/assay) and specific (cross-reactivity with cortisol, 0.24%) for clinical use and could be used to determine serum 11-DC levels after a simple solvent extraction. The anti-idiotype scFv–enzyme fusion proteins proposed here can be prepared reproducibly as homogeneous products with a 1:1 coupling ratio and would facilitate standardization of immunoassays for small biomarkers.